- Autophagy Inhibition in Pancreatic Adenocarcinoma
Brian A. Boone et al, 2017, Clinical Colorectal Cancer CrossRef - Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA.
Simon Heine et al, 2018, J Hematol Oncol CrossRef - Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways.
Lokman Varisli et al, 2020, Immunology CrossRef - Targeting Autophagy in Breast Cancer
Stefania Cocco et al, 2020, IJMS CrossRef - Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines
Bashir Lawal et al, 2021, Biomedicines CrossRef - Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges
Marika A. V. Reinius et al, 2021, Expert Rev. Mol. Med. CrossRef - mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership
Angel Cayo et al, 2021, IJMS CrossRef - Analyzing the scaffold diversity of cyclin‐dependent kinase inhibitors and revisiting the clinical and preclinical pipeline
Deendyal Bhurta et al, 2021, Med Res Rev CrossRef - Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
Oana-Maria Thoma et al, 2021, Front. Pharmacol. CrossRef - The Intricate Interplay between Cell Cycle Regulators and Autophagy in Cancer
Dorian V. Ziegler et al, 2021, Cancers CrossRef - TCP1 mediates gp37 of avian leukosis virus subgroup J to inhibit autophagy through activating AKT in DF-1 cells
Xinheng Zhang et al, 2022, Veterinary Microbiology CrossRef - Flavopiridol Protects against Fungal Keratitis due to Aspergillus fumigatus by Alleviating Inflammation through the Promotion of Autophagy
Lingwen Gu et al, 2022, ACS Infect. Dis. CrossRef -
The prolyl hydroxylase
OGFOD1
promotes cancer cell proliferation by regulating the expression of cell cycle regulators
Toshiya Fujisaki et al, 2022, FEBS Letters CrossRef - Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer
Zhaoliang Yu et al, 2024, Proc. Natl. Acad. Sci. U.S.A. CrossRef